August - 2024

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Scientists and clinicians at St. Jude Children’s Research Hospital identified the genetic vulnerability BARD1 in a patient with pediatric...

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma

The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights...

New research from Children’s Hospital of Philadelphia and St. Jude poised to transform approach to diagnosing and treating acute leukemia in children

Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology...

Researchers enhance natural killer cells to target pediatric brain cancer

In work published in Bioactive Materials , a research team led by Department of Chemistry and Biochemistry Professor Qing-Xiang "Amy"...

Scientists identify genes linked to relapse in the most common form of childhood leukemia

Researchers identified genetic predictors of relapse in standard risk B-cell acute lymphoblastic leukemia highlighting the role of...

Air pollution linked to worse childhood cancer survival

Exposure to air pollution is associated with worse overall survival (OS) among children with cancer, shows a large US study. Read more:...

Discovery of Key Genetic Driver in Neuroblastoma Paves Way to New Therapeutic Approaches

Led by the Children’s Cancer Institute , a multi-institutional study published in Nature Communications has shown for the first time...

UCLA launches groundbreaking clinical trial for vaccine targeting aggressive pediatric brain cancer

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive...

Improved chemokine homing enhances CAR T-cell therapy for osteosarcoma

Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with...

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...

1

Strength in numbers: Cooperative group clinical trials move the needle against pediatric cancer

FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma

After my daughter's cancer, I wanted to control her entire life. Then she went to college.

When Childhood Cancer Survivors Face Sexual Challenges

Early interventions may improve long-term academic achievement in young childhood brain tumor survivors

Immunotherapy for children with primary liver carcinomas: Research offers new hope

Pediatric psychologist explains how to support your child's development after a cancer diagnosis

Adult Survivors of Childhood Cancer Have High Prevalence of Chronic Pain

Spontaneous Remission in Childhood Cancer Rare but Fleeting

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition